Results 181 to 190 of about 66,038 (239)

Contribution of fungal diseases to the U.S. chronic disease burden. [PDF]

Clin Microbiol Rev
Ghai RR, Benedict K, Chiller TM, Chow NA, Hennessee IP, Jones S, Lockhart SR, Lyman M, Smith DJ, Toda M, Gold JAW.   +10 more
europepmc   +1 more source

Pulmonary sarcoidosis complicated with pulmonary cryptococcosis: a case report. [PDF]

Front Med (Lausanne)
Wang S, Wang X, Sun K, Jin Z, Ma J.
europepmc   +1 more source

The therapeutic effect of 5-nitro-8-hydroxyquinoline on <i>Aspergillus fumigatus</i>: results from <i>in vitro</i> and <i>in vivo</i> models of invasive aspergillosis. [PDF]

Front Cell Infect Microbiol
Ran J, Zhou X, Gao Z, Huan X, Zeng M, Tu Z.   +5 more
europepmc   +1 more source

Rhino-orbito-cerebral Rhizopus delemar infection in a patient with anti-melanoma differentiation-associated-5-positive dermatomyositis diagnosed by metagenomic next-generation sequencing: a case report. [PDF]

BMC Infect Dis
Peng Z, He H, Zhou S, Qiao L, Wang Q, Li M, Zhao Y.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Histopathology of fungal diseases of the lung

Seminars in Diagnostic Pathology, 2017
Fungal pneumonias can be a diagnostic problem. However, their recognition is important as they can pose a significant health risk, especially in the immunocompromised host. While many of these infections are accompanied by necrotizing or non-necrotizing granulomas, some might be characterized by cellular interstitial pneumonia, intra-alveolar frothy ...
Anja C, Roden, Audrey N, Schuetz
openaire   +2 more sources

Current Therapy of Major Fungal Diseases of the Lung

Infectious Disease Clinics of North America, 1991
The treatment of the major systemic fungi encountered in the United States--Histoplasma capsulatum, Blastomyces dermatitides, and Coccidioides immitis--depends on an understanding of the natural history of disease. Clinical manifestations of these infections can range from an asymptomatic disease that requires no therapy to an illness that is incurable
P, Johnson, G, Sarosi
openaire   +2 more sources

Progress and challenges in fungal lung disease in cystic fibrosis

Current Opinion in Pulmonary Medicine, 2022
Purpose of review This review is an overview of the recent progress made for the diagnosis and understanding of fungal lung disease in people with cystic fibrosis (CF), with a focus on Aspergillus fumigatus, the most common filamentous fungus in the CF airway. Currently, the longstanding question of the clinical significance of
openaire   +2 more sources